From Name:
From Email:
To Name:
To Email:

Optional Message:


University of Louisville technology that may inhibit pathway for cancer gets commercial partner

from UofL News

A University of Louisville-born invention that may help treat cancer now has a commercial partner. Qualigen Therapeutics Inc., a California biotechnology company focused on developing novel therapeutics for the treatment of cancer and infectious diseases, has signed a license agreement for the technology and plans to fund continued development with UofL to ready it for market. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063